Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 | Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC |
Others observations: INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS |
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 21.05. FÁRMACOS ANTIGLAUCOMATOSOS | No observations |
| List | Section | Observation |
|---|---|---|
| Peru | 21.4 Myotics and Anti-Glaucoma | No observations |
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Eent Glaucoma Drugs | No observations |
| Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. |
Others observations: X 5ml. |
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 45. Agentes oftalmológicos | No observations |
| El Salvador - 2019 | OFTALMOLÓGICOS | No observations |
| Barbados. Barbados National Drug Formulary (BNDF) | 52.40.28 EENT Prostaglandin Analogs | No observations |
| List | Section | Observation |
|---|---|---|
| Mexico. Cuadro Basico de Medicamentos - 2017 | 16. OFTALMOLOGIA | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 21.4. Miotics and antiglaucoma medicines | No observations |
| Guyana. Essential Medicines List. 2020-2021 | Prostaglandin analogue | No observations |
| Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 52:40 Antiglaucoma agents | No observations |
| Suriname. NGK-C-011 | 21.5 Miotics and agents in Glaucoma | No observations |
| Haiti. National List of Essential Medicines | 21.04. Miotics and Antiglaucoma | No observations |
| Bahamas. Drug Formulary | 15. 01 Antiglaucoma Agents | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | Prostaglandin Analogues | No observations |
| List | Section | Observation |
|---|---|---|
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | S: ÓRGÃOS SENSITIVOS | No observations |